Sensitive ASX Announcement

Neuren completes enrolment in Phelan-McDermid Phase 2 trial

Published: 30/06/23, 09:36am (AEST)2 pages
Neuren Pharmaceuticals Limited
NEU:ASXHealthcare

Recent NEU Announcements

Price Sensitive only